Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3w ago Cannabis greenmarketreport Views: 119

-

It seems Canadian cannabis consumers prefer to pay higher prices for flower. A new report from Cantor Fitzgerald’s analyst Pablo Zuanic found that most of the Canadian Licensed Producers (LP’s) increased market share with higher flower prices. The only exception to the rule was Organigram (NASDAQ: OGI), which saw its market jump dramatically after dropping prices almost by half.

Flower Power

Zuanic said he analyzed the 35 companies that accounted for 90% of Canadian flower sales in 2Q22 and looked at how those companies’ market share has changed over the last two years. Due to market competition, there are now 126 companies competing in the flower space versus just 53 two years ago.  Consumers are spreading their money around and the once-dominant flower sellers are now seeing lots of competition. For example, in 2Q20 just 10 LPs accounted for 90% of flower sales. Fast forward one year to 2021 and there were 19 LPs and in the most recent second quarter, 35 LPs.

He found that the bulk of the companies gaining market share in Canadian flower actually have prices above the market average, while those losing market share have prices below the market average and in most cases have also cut prices the most. He wrote, “We think the larger players for the most part may continue to lose market share, as price cuts are not enough. Sure, it is not just about better quality, but interesting that the ones gaining share are not price discounters (ankle biters, as called by some) but those with more premium offerings.”

Significant Growth

6 LPs grew their share of flower sales by more than 3pt.  The 6 LPs which grew their flower share by more than 3pt from 2Q20 to 2Q22 had an average price per gram of $5.13, 4% below the average price of $5.36. Zuanic’s hypothesis is that market share was gained with higher prices and this doesn’t seem to track, however, the price is only 4% below average. The losers had much bigger price drops.

Minor Growth

18 LPs grew their share of flower sales by between 1-2pt. The 18 LPs which grew their flower share between 1-2pt from 2Q20 to 2Q22 had an average price per gram of $7.78, 45% above the average price of $5.36.

Market Losses

The LP’s with market share losses ranging from 3pts. to 1 pt all had prices that were anywhere from 14% below the average flower price to 41% below average prices.

Organigram Bucks Trend

The big outlier was Organigram (NASDAQ: OGI) which saw its market share for flower, increasing share from 5% in 2Q20 to 12% in 2Q22. Zuanic wrote, “Organigram gained share by reducing their flower price per gram by 48% over the two-year period from $8.82 (5% premium to 2Q20 average price per gram of $8.37) to $4.56 (15% discount to 2Q22 average price per gram of $5.36).”

Other big losers included Aurora (NASDAQ: ACB) whose flower market share plunged from 21% in 2Q20 to 2% in 2Q22. Also losing share was Tilray (NASDAQ: TLRY) whose share decreased from 19% in 2Q20 to 8% in 2Q22.

In Closing

Zuanic believes that Canadian cannabis consumers are maturing and focusing more on quality than they had in the past. Cutting prices doesn’t seem to bring in more sales. It could also be that with more competition, consumers may have a harder time choosing which flower to buy. They could be opting for the higher-priced product in order to assure their money is well-spent.

Canadians Prefer To Pay Higher Prices For Flower on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.